Psoriasis Clinical Trial
CP-690-550 Ointment For Chronic Plaque Psoriasis
Summary
The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.
Eligibility Criteria
Inclusion Criteria:
Mild to moderate chronic plaque psoriasis (psoriasis vulgaris), with the duration of at least 6 months;
A target plaque of at least 9 sq. cm.
Exclusion Criteria:
Demonstrates "rebound" or "flare" of chronic plaque psoriasis;
Non plaque form of psoriasis;
Currently have or history of psoriatic arthritis;
Current drug induced psoriasis;
Currently on systemic therapy or was on systemic therapy for psoriasis within the previous 6 months;
Currently on phototherapy for psoriasis or was on phototherapy within the previous 3 months
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 11 Locations for this study
Mobile Alabama, 36608, United States
Los Angeles California, 90045, United States
Los Angeles California, 90045, United States
Orange Park Florida, 32073, United States
Omaha Nebraska, 68144, United States
Albuquerque New Mexico, 87106, United States
Rapid City South Dakota, 57702, United States
Dallas Texas, 75231, United States
Waterloo Ontario, N2J 1, Canada
Montreal Quebec, H2K 4, Canada
Montreal Quebec, H3Z 2, Canada
Quebec , G1V 4, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.